|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.44 USD | +1.67% |
|
-13.60% | -32.64% |
| 07-14 | Capricor Therapeutics Enters into Lease Agreement for New Headquarters in San Diego | CI |
| 06-29 | Capricor Therapeutics Gets FDA Advisory Panel Meeting for Duchenne Therapy | MT |
| Market Cap | 1.11B 968M 894M 823M 1.55B 107B 1.59B 10.68B 4.19B 52.19B 4.16B 4.07B 180B | P/E 2026 * |
-32.8x | P/E 2027 * | -29.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.11B 968M 894M 823M 1.55B 107B 1.59B 10.68B 4.19B 52.19B 4.16B 4.07B 180B | EV / Sales 2026 * |
9.38x | EV / Sales 2027 * | 9.05x |
| Free-Float |
90.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | +1.67% | ||
| 1 week | -13.60% | ||
| Current month | -19.27% | ||
| 1 month | -25.37% | ||
| 3 months | -43.80% | ||
| 6 months | -20.16% | ||
| Current year | -32.64% |
| 1 week | 18.64 |  | 21.53 |
| 1 month | 18.64 | | 30.93 |
| Current year | 18.64 | | 36.82 |
| 1 year | 4.3 | | 40.37 |
| 3 years | 2.68 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 44.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 19/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 31/12/2017 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 12/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Gotwals
BRD | Director/Board Member | 63 | 20/07/2023 |
George Dunbar
BRD | Director/Board Member | 79 | 19/11/2013 |
David Musket
BRD | Director/Board Member | 68 | 19/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/06/26 | Fiscal year | Chief Financial Officer | 72,300 | 0.1248% | ||
| 25/06/26 | Fiscal year | General Counsel | 72,300 | 0.1248% | ||
| 24/06/26 | Fiscal year | General Counsel | 1,200 | 0.0021% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.67% | -13.60% | +168.51% | +333.93% | 1.11B | |
| -7.17% | -2.63% | +49.59% | +74.24% | 55.98B | |
| +0.24% | -5.62% | +54.73% | +125.15% | 53.69B | |
| +0.80% | -8.41% | +3.57% | +425.83% | 23.29B | |
| -0.09% | -1.61% | -18.68% | -15.48% | 23.15B | |
| -5.95% | -0.22% | +35.96% | -9.58% | 20.58B | |
| -1.14% | -3.16% | +32.88% | -28.80% | 17.76B | |
| -5.16% | -7.00% | +177.56% | +326.39% | 16.09B | |
| -6.91% | +2.40% | +36.86% | +636.97% | 15.93B | |
| +0.43% | -2.07% | +24.79% | +188.40% | 14B | |
| Average | -2.33% | -2.63% | +56.58% | +205.70% | 24.16B | |
| Weighted average by Cap. | -2.90% | -2.26% | +44.16% | +157.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 118M 103M 95.28M 87.77M 166M 11.37B 169M 1.14B 447M 5.57B 443M 434M 19.17B | 122M 107M 98.72M 90.94M 171M 11.78B 175M 1.18B 463M 5.77B 459M 449M 19.86B |
| Net income | -28.4M -24.83M -22.92M -21.11M -39.82M -2.73B -40.69M -274M -108M -1.34B -107M -104M -4.61B | -48.17M -42.12M -38.87M -35.8M -67.52M -4.64B -69.01M -465M -182M -2.27B -181M -177M -7.82B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | US$19.44 | +1.67% | 1,164,677 |
| 16/07/26 | US$19.12 | -6.04% | 1,489,709 |
| 15/07/26 | US$20.35 | -1.60% | 1,371,340 |
| 14/07/26 | US$20.68 | +0.34% | 1,085,441 |
| 13/07/26 | US$20.61 | -4.18% | 1,275,169 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
